Evaluation of Atacand® (Candesartan) in Daily Medical Practice

AstraZeneca

Status: Completed

Conditions: Hypertension

Study type: Observational

Funder types: Industry

Identifiers

NCT00837720

NIS-CSI-ATA-2005/1

Details and patient eligibility

About

This open label, non-interventional study is to show the efficacy of antihypertensive treatment with Atacand in hypertensive patients. Efficacy is to be evaluated based on the difference in systolic and diastolic blood pressure at baseline and at both follow-up visits.

Enrollment: 750 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• a patient with arterial hypertension who has been prescribed Atacand according to physician's judgement, irrespective of the inclusion in the study

Exclusion criteria

• hypersensitivity to candesartan or any other ingredient of Atacand
• liver function impairment and/or cholestasis
• severe renal insufficiency
• woman of child-bearing potential and not using appropriate contraceptive measures, pregnancy or lactation